Is TNF-α gene polymorphism related to pulmonary functions and prognosis as determined by FEV1, BMI, COPD exacerbation and hospitalization in patients with smoking-related COPD in a Turkish population?

Rev Port Pneumol. 2014 Nov-Dec;20(6):305-10. doi: 10.1016/j.rppneu.2014.03.003. Epub 2014 May 10.

Abstract

Introduction: Some conflicting results have been published about the relationship between TNF-α-308 gene polymorphism and chronic obstructive pulmonary disease (COPD). The aim of this study was to determine whether TNF-α-308 gene polymorphism was associated with smoking-related COPD and whether it was associated with pulmonary function parameters (PFTs), body mass index (BMI), and prognosis.

Methods: We studied the frequencies of TNF-α-308 gene polymorphism in 90 male subjects (60 subjects with COPD and 30 healthy smokers) in a Caucasian population.

Results: There was no significant difference in the frequency of G/G and G/A gene polymorphisms in the COPD group compared with control subjects (p>0.05). We compared COPD patients as G/A gene polymorphism and G/G gene polymorphism; the PFTs and BMI before and after one year were not statistically significant (p>0.05). Also, the exacerbation and hospitalization data of COPD patients were not significant between these groups.

Conclusion: In conclusion, there was no difference between smoking-related COPD and the control group according to TNF α-308 gene polymorphism in a Caucasian population. In addition, it was shown that important determinants of prognosis of COPD such as FEV1, BMI, COPD exacerbation and hospitalization were not associated with TNF-α-308 gene polymorphism.

Keywords: Chronic obstructive pulmonary disease; Doença pulmonar obstrutiva crónica; Factor de necrose tumoral alfa; Genetics; Genética; Polimorfismo; Polymorphism; Tumor necrosis factor-α.

MeSH terms

  • Body Mass Index*
  • Disease Progression
  • Forced Expiratory Volume*
  • Hospitalization*
  • Humans
  • Lung / physiopathology*
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Prognosis
  • Pulmonary Disease, Chronic Obstructive / etiology*
  • Pulmonary Disease, Chronic Obstructive / genetics
  • Pulmonary Disease, Chronic Obstructive / physiopathology*
  • Smoking / adverse effects*
  • Tumor Necrosis Factor-alpha / genetics*
  • Turkey

Substances

  • Tumor Necrosis Factor-alpha